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Background: Increased production of free radicals and oxidative stress in type II diabetic patients could be one of the probable 
causes for development of complications. The authors hypothesise that such a mechanism also contributes to the development 
of diabetic nephropathy in those patients.
Aim: The aim of this study was to evaluate the association of DNA fragmentation damage with diabetic nephropathy in type II 
diabetes mellitus, so as to use it as a future novel predictive marker.
Patients and methods: The study population included 100 patients with diabetic nephropathy, 100 diabetic patients without 
nephropathy and 100 healthy volunteers as controls. Lipid profile, fasting and post-prandial blood glucose, micro-albuminuria 
(micro-alb) and glycosylated haemoglobin (HbA1c) were assessed in patients and controls. The technique of capillary 
electrophoresis was used to detect DNA damage.
Results: The frequency of DNA damage in peripheral blood mononuclear cells was 71% in diabetic nephropathy compared with 
45% in non-nephropathy patients (p < 0.001). None of healthy controls showed such a finding. Oxidative DNA fragmentation 
in the diabetic nephropathy group was 3.06 times that in the non-nephropathy group. Neither poor glycaemic control nor 
dyslipidaemia contributed to DNA damage in diabetic patients. Multivariate analysis showed that positive oxidative DNA damage 
test (OR1.58, p = 0.02) and the duration of ongoing DM (OR 1.48, p = 0.004) were the only independent factors contributing to 
the occurrence of diabetic nephropathy.
Conclusion: Type II diabetic patients have more liability to oxidative DNA damage in general with a significantly higher frequency 
in diabetic nephropathy. DNA fragmentation analysis can be used as a predictive diagnostic biomarker for diabetic nephropathy.
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Introduction
Diabetes mellitus is a real problem that influences the world as a 
whole and Egypt in particular. The World Health Organization 
estimated that the world prevalence of DM among adults was 
6.4%, affecting 285 million adults in 2010 with an expected rise 
to 7.7%, affecting 439 million adults, by 2030. Between 2010 and 
2030, there will be a 69% increase in numbers of adults with 
diabetes in developing and 20% increase in developed countries.1 
The current prevalence of diabetes in adults in the region is 
estimated to be around 9.2%. Of the 34 million people affected 
by diabetes, nearly 17 million were undiagnosed and therefore, 
they would be at considerable risk of diabetic complications and 
poor health outcomes.2
Diabetic nephropathy is a major cause of end-stage renal disease 
(ESRD) worldwide. Prevalence of diabetic nephropathy gradually 
increased from 8.9% in 1996, to 14.5% in 2001. The mean age of 
patients with diabetic nephropathy-related ESRD was 
significantly higher than that of ESRD from other causes. 
Mortality was also significantly higher in diabetic patients with 
ESRD.3 In diabetic nephropathy there is a progressive decline in 
the glomerular filtration rate, characterised by glomerular hyper-
filtration, glomerular and tubular epithelial hypertrophy, 
increased urinary albumin excretion, increased basement 
membrane thickness and mesangial expansion with the 
accumulation of extracellular matrix proteins (ECM).4 Increased 
renal advanced glycation end-products (AGE) in diabetic patients 
have been linked to structural abnormality observed in diabetic 
nephropathy such as mesangial expansion, glomerular basement 
membrane thickening and tubular-interstitial fibrosis.5 Reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) are the 
terms collectively describing free radicals and other non-radical 
reactive derivatives, also called oxidants. Biological free radicals 
are highly unstable molecules that are products of normal 
cellular metabolism. They have electrons available to react with 
various organic substrates such as lipids, proteins and 
deoxyribonucleic acid (DNA). Free radicals are well recognised 
for playing a dual role as both deleterious and beneficial species, 
since they can be either harmful or beneficial to living systems.6
Numerous experimental evidences have highlighted a direct link 
between oxidative stress and diabetes through the measurement 
of oxidative stress biomarkers in both diabetic patients and 
rodents. A hyperglycaemic state can lead to an increase in the 
levels of oxidative DNA damage markers such as 8-hydroxy-2’-
deoxyguanosine (8-OHdG), 8-oxo-7, 8-dihydro-2’-
deoxyguanosine (8-oxodG), lipid-peroxidation products 
measured as thiobarbituric acid-reactive substances (TBARS), 
protein oxidation products such as nitrotyrosine and carbonyl. In 
the meantime they can all lower the activity of antioxidant 
enzymes.7,8 Due to the ability of ROS to directly oxidise and 
damage DNA, proteins and lipids, free radicals are believed to 
play a key role in the onset and progression of late diabetic 
complications.9
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During the last decade, capillary electrophoresis applied to the 
biological systems is emerging as a new bio-analytical method 
with the advantages of fast analysis time, automation, on-
column injection and detection, reproducible analysis and high 
resolving power for the separation testing of double-stranded 
(ds) DNA fragments.10,11 It is a sensitive, simple, inexpensive and 
rapid method that can be used to detect DNA damage to the 
individual cells and reveal the presence of double-strand breaks, 
single-strand breaks and alkali-labile sites.11,12
Therefore, this study was planned to focus on the relationship 
between frequency occurrence of DNA damage in type II diabetic 
individuals and the presence of diabetic nephropathy, with 
assessment of its validity as a possible diagnostic biomarker for 
detection of diabetic nephropathy.
Patients and methods
This is a cross-sectional study that was carried out in the diabetes 
outpatient clinic and clinical pathology unit at Suez Canal 
University, Egypt. The study population consisted of 1 009 
consecutive patients with diabetic nephropathy (Group 1), 100 
age-matched diabetic patients without nephropathy (Group 2) 
and 100 healthy volunteers (Group 3) as controls. Data were 
collected after obtaining informed consent from all subjects 
using an interview questionnaire. All individuals were subjected 
to a complete history, physical examination (height, weight and 
BMI were calculated) and laboratory investigations. Groups 1 
and 2 comprised patients known to have type II diabetes mellitus 
diagnosed according to ADA guidelines.
Diabetic nephropathy was diagnosed if the patient had positive 
urinary albumin determined by immunoassay using a morning 
spot urine, urinary albumin/creatinine ratio ranging from 30 to 
299 mg/g creatinine in two or more of three specimens or either 
urinary albumin excretion rate of 30–299  mg/24 hr urine 
collection or 20–199 µg/min in timed urine collection.
Patients with either type I diabetes mellitus who refused to 
participate, with chronic cardiovascular, lung or liver disease or 
micro-albuminuria associated with a non-diabetic cause were 
excluded from the study.
A 10 ml blood specimen was collected from each patient in the 
first session and 3 ml in the second session as follows. In the first 
session 4 ml of blood was collected and divided into two EDTA 
tubes, one for DNA extraction and the other for glycated 
haemoglobin measurement, while 3 ml of blood was collected 
after 8 h fasting in a sterile plain tube for measuring of fasting 
blood sugar; 3.0 ml of blood was collected after 12 h fasting in a 
sterile plain tube for measuring triglycerides, cholesterol and 
high-density lipoprotein. In the second session 3 ml of blood was 
collected (2 h post-prandial) in a sterile plain tube for measuring 
post-prandial blood sugar. A spot urine sample was taken for 
micro-albumin measurement.
Lipid profile, micro-albuminuria, FBS, PPS and HbA1c were 
analysed using a Cobas 6000 auto-analyser (Roche Diagnostics 
GmbH, Mannheim, Germany).
DNA extraction and fragmentation analysis
Genomic DNA was extracted from peripheral blood using 
avcommercially available spin-column technique kit for DNA 
extraction (QIAamp®DNA Blood Mini Kit) according to the 
manufacturer’s instructions (QIAGEN, Inc, Hilden, Germany). 
DNA yield and purity was assessed using a spectro-
photometrically Thermo Scientific NanoDrop™ 
Spectrophotometer (Nanodrop) (Thermo Fisher Scientific Inc, 
Waltham, MA, USA).
Analysis of DNA degradation was done using QIAxcel DNA Kits 
for automated analysis of DNA fragments using a QIAxcel 
capillary electrophoresis instrument that provides robust results 
for nucleic acid concentrations as low as 0.1 ng/μl and accurate 
analyses with resolution down to 3–5 bp. After processing, the 
data are displayed as an electropherogram or gel image.
Results
The study groups were matched for gender distribution. 
Regarding age, the three groups were divided into 
46.41 ± 14.47 years, 52.95 ± 13.25 years and 33.8 ± 10.45 years 
respectively. The mean body mass index was 31.31 ± 4.57 kg/m2 
in group 1 compared with 30.5 ± 4.78 kg/m2 and 26.6 ± 5.02 kg/ 
m2 in groups 2 and 3 respectively (p = 0.008 and 0.009). The mean 
duration of diabetes was 5.57 ± 2.5 years in group 1 compared 
with 4.35 ± 1.95 years in group 2 (Table 1).
There was no statistically significant difference regarding level of 
total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol 
or HbA1c among the diabetic nephropathy and non-nephropathy 
groups (Table 2). However, there was a statistically significant 
difference in the mean levels of total cholesterol, triglycerides, 
LDL-cholesterol and HbA1c among diabetic patients in groups 1 
and 2 and the healthy volunteer group 3 (p = 0.0008, 0.0001, 
0.001, 0.0001 respectively).
Our study showed that there was DNA damage among patients 
in group 1 (71.3%), as well as among the patients in the second 
group (45%) with a statistically significant difference (p < 0.001). 
Also, there was a statistically significant difference between the 
two groups regarding quantitation of oxidative DNA damage 
(3.65 ± 5.8 vs. 0.9 ± 1.3, p = 0.014). The study showed a higher 
presence of oxidative DNA damage among smokers in 
comparison with non-smokers (55% vs. 16%). This notification 
could help to discover other mechanisms that may be 
incriminated in the pathogenesis of DM complications.
Table 1: Demographic data of studied population






Median (IQR) Median (IQR) Median 
(IQR)
Age 46.41 ± 14.47 52.95 ± 13.25 33.8 ± 10.45
48 (22) 57 (20) 31 (11)
Duration of DM (years) 5.57 ± 2.5 4.35 ± 1.95 –
5 (3) 4.5 (3)
Sex Male, n (%) 24 (24%) 40 (40%) 50 (50%)





70 (70%) 70 (70%) 100 (100%)





61 (61%) 60 (60%) 90 (90%)
Positive, n (%) 39 (39%) 40 (40%) 10 (10%)
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Multivariate analysis showed that the positive oxidative DNA 
damage test (OR1.58, p = 0.02) and the duration of current DM 
(OR 1.48, p = 0.004) were the only independent factors 
contributing to the occurrence of diabetic nephropathy. The 
ROC curve for quantity of DNA fragmentation in relation to 
diabetic nephropathy was studied. The cut-off point of DNA 
fragmentation for diagnosis of diabetic nephropathy was 1 
strand break with an area under the curve of 0.7466, which 
provides a sensitivity of 71.43% and a specificity of 70.00%.
Discussion
The present study reported increased oxidative DNA damage in 
peripheral blood leucocytes of diabetic nephropathy compared 
with non-nephropathy patients. Moreover, DNA fragmentation 
was exclusively found in more than two-thirds of diabetic 
nephropathy patients compared with none of the healthy 
control group. Previous studies concerning DNA damage and 
diabetes revealed contradictory results. Several studies showed 
an increased extent of DNA damage in type II diabetic patients 
compared with controls.13 On the other hand, other studies 
showed a lack of association between diabetes and increased 
DNA damage levels.14 The discrepancy between different studies 
is possibly due to differences in glycaemic control, patient age, 
and duration of diabetes, treatment methods and techniques 
used to measure oxidative stress.13
Goodarzi et al.12 reported on a significant positive correlation 
between urinary 8-OHdG, a biomarker of oxidative DNA damage, 
and both fasting blood glucose and HbA1c. In the present study, 
there was no correlation between DNA damage and either blood 
sugar or HbA1c. Theoretically speaking, hyperglycaemia causes 
glucose auto-oxidation, glycation of proteins, activation of 
polyol metabolism and subsequent formation of ROS. It has also 
been demonstrated that hyperglycaemia is associated with an 
increased production of free radicals in the mitochondria and 
may contribute to greater DNA damage.15
The study did not find any statistically significant difference 
between duration of diabetes and DNA damage. This has been 
reported by other authors. In diabetes, Ibarra-Costilla and his 
colleagues11 suggested that long-term chronic exposure causes 
adaptation of response to damage and produces less genetic 
damage than initial exposure.
One of the complications of diabetes is nephropathy. Diabetic 
nephropathy is associated with DNA damage that increases with 
progression of nephropathy. In the current study, there was a 
statistically significant positive correlation between quantitative 
DNA damage and severity of micro-albuminuria. Such a finding 
was also supported by Hinokio et al.,14 who reported a significant 
positive correlation between 8-oxo, 2′-deoxy-guanosine in urine 
as a marker for oxidative stress and micro-albuminuria among 
type II diabetic patients.
In this study, there is no statistically significant correlation 
between DNA damage and either serum total cholesterol, 
triglycerides, HDL-cholesterol, LDL-cholesterol or BMI. Other 
studies have revealed increased DNA damage in obesity with a 
significant positive correlation with cholesterol, triglycerides and 
LDL-cholesterol. Also, DNA damage was present in atherosclerotic 
plaques and in circulating cells of patients with atherosclerosis.15 
It is not known whether DNA damage in diabetes directly 
Table 2: Background characteristics of studied population
Lab and exam characteristics With nephropathy Without nephropathy Control
Mean ± SD Mean ± SD Mean ± SD
Median (IQR) Median (IQR) Median (IQR)
BMI (kg/m2) 31.31 ± 4.57 30.5 ± 4.78 26.6 ± 5.02
30 (4) 29.5 (6) 27 (4)
Cholesterol (mg/dl) 209.35 ± 8.19 214.65 ± 48.54 156.5 ± 20.07
202 (61) 208 (46.5) 150 (30)
TG (mg/dl) 174 ± 87.45 146.15 ± 68.29 63.1 ± 20.98
164 (118) 127.5 (90.5) 62 (31)
HDL (mg/dl) 45.43 ± 13.69 44.9 ± 12.4 54 ± 13.06
3 (14) 46.5 (19) 50.5 (20)
LDL (mg/dl) 128.65 ± 36.89 140.5 ± 46.34 84.6 ± 26.25
123 (51) 141 (25) 80 (47)
FBS (mg/dl) 191.31 ± 85.33 158.2 ± 65.21 87.7 ± 8.92
164 (116) 144 (100.5) 85 (7)
PP (mg/dl) 298.55 ± 102.74 258.8 ± 107.78 121.3 ± 14.94
272 (181) 261 (178.5) 117.5 (15)
HbA1C (%) 8.96 ± 2.14 8.74 ± 1.98 5.24 ± 0.43
8.8 (3.2) 8.85 (2.4) 5.2 (0.4)
ALB (mg/l) 64.98 ± 39.38 16.2 ± 7.04 16.5 ± 6.6
50 (35) 16 (10.5) 15 (7)
Fundus Negative, n (%) 45 (45%) 35 (35%) 90 (90%)
Exam Positive, n (%) 55 (55%) 65 (65%) 10 (10%)
DNA Negative, n (%) 29 (29%) 55 (55%) 100 (100%)
Fragmentation Positive, n (%) 71 (71%) 45 (45%) 0 (0%)
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During the last decade, capillary electrophoresis applied to the 
biological systems is emerging as a new bio-analytical method 
with the advantages of fast analysis time, automation, on-
column injection and detection, reproducible analysis and high 
resolving power for the separation testing of double-stranded 
(ds) DNA fragments.10,11 It is a sensitive, simple, inexpensive and 
rapid method that can be used to detect DNA damage to the 
individual cells and reveal the presence of double-strand breaks, 
single-strand breaks and alkali-labile sites.11,12
Therefore, this study was planned to focus on the relationship 
between frequency occurrence of DNA damage in type II diabetic 
individuals and the presence of diabetic nephropathy, with 
assessment of its validity as a possible diagnostic biomarker for 
detection of diabetic nephropathy.
Patients and methods
This is a cross-sectional study that was carried out in the diabetes 
outpatient clinic and clinical pathology unit at Suez Canal 
University, Egypt. The study population consisted of 1 009 
consecutive patients with diabetic nephropathy (Group 1), 100 
age-matched diabetic patients without nephropathy (Group 2) 
and 100 healthy volunteers (Group 3) as controls. Data were 
collected after obtaining informed consent from all subjects 
using an interview questionnaire. All individuals were subjected 
to a complete history, physical examination (height, weight and 
BMI were calculated) and laboratory investigations. Groups 1 
and 2 comprised patients known to have type II diabetes mellitus 
diagnosed according to ADA guidelines.
Diabetic nephropathy was diagnosed if the patient had positive 
urinary albumin determined by immunoassay using a morning 
spot urine, urinary albumin/creatinine ratio ranging from 30 to 
299 mg/g creatinine in two or more of three specimens or either 
urinary albumin excretion rate of 30–299  mg/24 hr urine 
collection or 20–199 µg/min in timed urine collection.
Patients with either type I diabetes mellitus who refused to 
participate, with chronic cardiovascular, lung or liver disease or 
micro-albuminuria associated with a non-diabetic cause were 
excluded from the study.
A 10 ml blood specimen was collected from each patient in the 
first session and 3 ml in the second session as follows. In the first 
session 4 ml of blood was collected and divided into two EDTA 
tubes, one for DNA extraction and the other for glycated 
haemoglobin measurement, while 3 ml of blood was collected 
after 8 h fasting in a sterile plain tube for measuring of fasting 
blood sugar; 3.0 ml of blood was collected after 12 h fasting in a 
sterile plain tube for measuring triglycerides, cholesterol and 
high-density lipoprotein. In the second session 3 ml of blood was 
collected (2 h post-prandial) in a sterile plain tube for measuring 
post-prandial blood sugar. A spot urine sample was taken for 
micro-albumin measurement.
Lipid profile, micro-albuminuria, FBS, PPS and HbA1c were 
analysed using a Cobas 6000 auto-analyser (Roche Diagnostics 
GmbH, Mannheim, Germany).
DNA extraction and fragmentation analysis
Genomic DNA was extracted from peripheral blood using 
avcommercially available spin-column technique kit for DNA 
extraction (QIAamp®DNA Blood Mini Kit) according to the 
manufacturer’s instructions (QIAGEN, Inc, Hilden, Germany). 
DNA yield and purity was assessed using a spectro-
photometrically Thermo Scientific NanoDrop™ 
Spectrophotometer (Nanodrop) (Thermo Fisher Scientific Inc, 
Waltham, MA, USA).
Analysis of DNA degradation was done using QIAxcel DNA Kits 
for automated analysis of DNA fragments using a QIAxcel 
capillary electrophoresis instrument that provides robust results 
for nucleic acid concentrations as low as 0.1 ng/μl and accurate 
analyses with resolution down to 3–5 bp. After processing, the 
data are displayed as an electropherogram or gel image.
Results
The study groups were matched for gender distribution. 
Regarding age, the three groups were divided into 
46.41 ± 14.47 years, 52.95 ± 13.25 years and 33.8 ± 10.45 years 
respectively. The mean body mass index was 31.31 ± 4.57 kg/m2 
in group 1 compared with 30.5 ± 4.78 kg/m2 and 26.6 ± 5.02 kg/ 
m2 in groups 2 and 3 respectively (p = 0.008 and 0.009). The mean 
duration of diabetes was 5.57 ± 2.5 years in group 1 compared 
with 4.35 ± 1.95 years in group 2 (Table 1).
There was no statistically significant difference regarding level of 
total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol 
or HbA1c among the diabetic nephropathy and non-nephropathy 
groups (Table 2). However, there was a statistically significant 
difference in the mean levels of total cholesterol, triglycerides, 
LDL-cholesterol and HbA1c among diabetic patients in groups 1 
and 2 and the healthy volunteer group 3 (p = 0.0008, 0.0001, 
0.001, 0.0001 respectively).
Our study showed that there was DNA damage among patients 
in group 1 (71.3%), as well as among the patients in the second 
group (45%) with a statistically significant difference (p < 0.001). 
Also, there was a statistically significant difference between the 
two groups regarding quantitation of oxidative DNA damage 
(3.65 ± 5.8 vs. 0.9 ± 1.3, p = 0.014). The study showed a higher 
presence of oxidative DNA damage among smokers in 
comparison with non-smokers (55% vs. 16%). This notification 
could help to discover other mechanisms that may be 
incriminated in the pathogenesis of DM complications.
Table 1: Demographic data of studied population






Median (IQR) Median (IQR) Median 
(IQR)
Age 46.41 ± 14.47 52.95 ± 13.25 33.8 ± 10.45
48 (22) 57 (20) 31 (11)
Duration of DM (years) 5.57 ± 2.5 4.35 ± 1.95 –
5 (3) 4.5 (3)
Sex Male, n (%) 24 (24%) 40 (40%) 50 (50%)





70 (70%) 70 (70%) 100 (100%)





61 (61%) 60 (60%) 90 (90%)
Positive, n (%) 39 (39%) 40 (40%) 10 (10%)
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promotes atherosclerosis, or is a by-product of dyslipidaemia of 
diabetes.
Conclusion
Type II diabetic patients have more liability to oxidative DNA 
damage in general with a significantly higher frequency in 
diabetic nephropathy compared with non-nephropathy patients. 
DNA fragmentation analysis can be used as a valuable diagnostic 
biomarker for diabetic nephropathy.
Table 3: Background characteristics of DNA fragmentation in positive 
and negative diabetics
Mann–Whitney test used for quantitative data and chi-square test for qualitative 
data.
Patient characteristics DNA fragmentation p-value
Negative Positive 
Mean ± SD Mean ± SD
Median (IQR) Median (IQR)
Age (years) 51.08 ± 14.02 46.73 ± 14.44 0.233
54 (18) 46.5 (22)
Duration (years) 5.08 ± 2 5.3 ± 2.63 0.845
5 (2) 5 (4)
BMI (kg/m2) 31.24 ± 5.26 30.98 ± 4.27 0.866
31 (7) 30 (4.5)
Sex Male, n (%) 20 (20%) 34 (34%) 0.215
Female, n (%) 80 (80%) 66 (66%)
Family Negative, n (%) 52 (52%) 65 (65%) 0.255
History Positive, n (%) 48 (48%) 35 (34%)
Smoking Negative, n (%) 84 (84%) 62 (62%) 0.05
Positive, n (%) 16 (16%) 38 (38%)
Cholesterol (mg/dl) 212.64 ± 37.23 209.89 ± 53.53 0.649
203 (46) 202 (59)
TG (mg/dl) 172.76 ± 67.12 162.16 ± 91.1 0.289
166 (90) 139 (157)
HDL (mg/dl) 43.2 ± 10.47 46.45 ± 14.56 0.198
39 (10) 46.5 (16.5)
LDL (mg/dl) 132.04 ± 30.17 132.11 ± 44.79 0.97
134 (29) 128 (44.5)
FBS (mg/dl) 168.4 ± 69.96 189.27 ± 86.46 0.372
138 (75) 167.5 (115.5)
PP (mg/dl) 281.72 ± 109.38 290.05 ± 103.61 0.658
260 (160) 269 (161)
HbA1C (%) 8.7 ± 1.88 9 ± 2.21 0.649
8.5 (2.6) 8.95 (3.3)
ALB (mg/l) 37.64 ± 25.21 58.34 ± 45.01 0.056
40 (27) 44 (37.5)
Fundus Negative, n (%) 32 (32%) 47 (47%) 0.2
Exam Positive, n (%) 68 (68%) 53 (53%)
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